Insider Stock Trading History of Bilenker Joshua H.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bilenker Joshua H. since year 2005. The trader's CIK number is 1612312. At the time of this reporting, Bilenker Joshua H. is the President & CEO of Loxo Oncology, Inc. . (stock ticker symbol LOXO). See this page for all insider trading activities at Loxo Oncology, Inc. .


Stock purchases, sales, and option exercises reported by insider Bilenker Joshua H. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-30 LOXO Loxo Oncology, Inc. Option Ex 7,500 1.18 8,880
2017-10-31 LOXO Loxo Oncology, Inc. Option Ex 7,500 1.18 8,880
2017-10-30 LOXO Loxo Oncology, Inc. Sale 7,500 87.80 658,470
2017-10-31 LOXO Loxo Oncology, Inc. Sale 7,500 86.83 651,247
2017-09-18 LOXO Loxo Oncology, Inc. Option Ex 7,500 1.18 8,880
2017-09-19 LOXO Loxo Oncology, Inc. Option Ex 7,500 1.18 8,880
2017-09-18 LOXO Loxo Oncology, Inc. Sale 7,500 89.36 670,222
2017-09-19 LOXO Loxo Oncology, Inc. Sale 7,500 88.78 665,812
2017-08-15 LOXO Loxo Oncology, Inc. Option Ex 7,500 1.18 8,880
2017-08-14 LOXO Loxo Oncology, Inc. Sale 7,500 73.83 553,740
2017-08-15 LOXO Loxo Oncology, Inc. Sale 7,500 73.58 551,865
2017-08-14 LOXO Loxo Oncology, Inc. Option Ex 7,500 1.18 8,880

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bilenker Joshua H. (President & CEO of Loxo Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.